Streetbeat News

Stock Prices

INVO

Shares of INVO BioScience were halted on a circuit breaker due to a sharp downside movement. Despite this, the stock is still up by 251.8%.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:48 pm

XOM

A significant amount of unusual options activity has been observed for Exxon Mobil (NYSE:XOM), with a roughly equal split between bullish and bearish expectations. The trades include 2 puts worth $167,140 and 8 calls worth $615,270. Whales have been targeting a price range from $70.0 to $130.0 for Exxon Mobil over the last 3 months. The current price of XOM is $110.57, down 0.46%. Several financial institutions have given their ratings and price targets for XOM, with the highest being $145 by Jefferies.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:45 pm

AVGO

A significant investor has taken a bearish stance on Broadcom (NASDAQ:AVGO), with 78% of the detected trades being bearish and 21% bullish. The trades include 8 puts amounting to $452,383 and 6 calls amounting to $549,994. The whales have been targeting a price range from $250.0 to $1130.0 for Broadcom over the last 3 months. The price of AVGO is up 0.24% at $855.66, and RSI indicators suggest the stock may be approaching overbought.

Portfolio Pulse from Benzinga Insights

October 23, 2023 | 1:45 pm

AKU

INVO

LICY

LMDX

RVMD

XRTX

US stocks traded lower with the Dow Jones index falling over 100 points. The Chicago Fed National Activity Index increased to +0.02 in September from -0.22 in the prior month. LumiraDx Limited, INVO Bioscience, and Akumin Inc. saw their shares rise after various strategic collaborations and agreements. Li-Cycle Holdings Corp., Revolution Medicines, and XORTX Therapeutics saw their shares drop due to halted projects and clinical trial data.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 1:43 pm

OKTA

Okta Inc's shares are trading lower due to continued momentum after a security breach. The company stated that a threat actor gained unauthorized access to its support management system and viewed files from certain customers. Okta's production service and Auth0/CIC case management system were not impacted. Following the incident, Keybanc analyst Michael Turits maintained an Overweight rating for Okta but lowered the price target from $106 to $95.

Portfolio Pulse from Adam Eckert

October 23, 2023 | 1:42 pm

INVO

Shares of INVO BioScience have been halted on a circuit breaker to the upside, with the stock now up 233.2%.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:41 pm

BSVUSD

BTCUSD

ETHUSD

FTMUSD

Bitcoin (BTC) and Ethereum (ETH) traded higher, with BTC surpassing the $30,500 level and ETH trading above the $1,600 mark. Fantom (FTM) was the top gainer over the past 24 hours, while Bitcoin SV (BSV) was the biggest loser. The global crypto market cap rose to $1.16 trillion, recording a 24-hour gain of 1.8%.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 1:40 pm

BOH

Bank Of Hawaii Corp (NYSE:BOH) reported Q3 FY23 revenues of $171.27 million, beating the analyst consensus estimate of $160.74 million. The quarterly EPS of $1.17 also surpassed the consensus of $0.97. Total deposits increased by 1.4% from the previous quarter to $20.8 billion. However, net interest income decreased by 2.7% Q/Q and 14.6% Y/Y to $120.9 million. Noninterest income rose by 16.4% from the previous quarter to $50.3 million. The company declared a dividend of $0.70, payable on December 14, 2023.

Portfolio Pulse from Shivani Kumaresan

October 23, 2023 | 1:40 pm

INVO

Shares of INVO BioScience have resumed trading.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:36 pm

INVO

Shares of INVO BioScience have been halted on a circuit breaker to the upside, with the stock now up 209.3%.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:33 pm